NCT07436637
Guardant Shield Colorectal Cancer Screening
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Final enrollment: 2 participants, under 1% of the 500 planned
- Enrollment closed, study ongoing
- Site details revised
- Notable Eligibility criteria expanded, about 10 words
- Site contact updated
- Notable Recruitment opened
- Start date changed from estimate of Jun 30, 2026 to Jul 22, 2026
- Site details revised
- Notable Start date: May 30, 2026 to Jun 30, 2026v4
- Notable Start date: Apr 1, 2026 to May 30, 2026v3
- Notable Eligibility criteria expanded, about 5 wordsv2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Arms and interventions
Participants in this group will receive a standard screening reminder via mailed letter or, if they have an active patient portal account through the University of Miami health (UHealth) portal. Total participation duration is approximately nine (9) months.
Participants in this group will receive a similar reminder, but with the additional option of completing a blood-based screening test (ShieldTM). Communication will be delivered via mailed letter or the UHealth patient portal. Total participation duration is approximately nine (9) months.
Behavioral: Screening Reminder
Procedures: Blood Sample Collection
Sites
1 site in 1 country
- University of MiamiMiami, Florida, United States